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 Introduction: Pseudomonas aeruginosa is an 
opportunistic pathogen and causes of nosocomial 
infections in hospitals. Due to high antibiotic resistance 
and the ability to develop new resistance during antibiotic 
treatment, P. aeruginosa infection is difficult to eradicate 
because physical therapy becomes difficult and 
ineffective. This study aims to evaluate the antibiotic 
sensitivity pattern of P. aeruginosa strains at two different 
hospitals in Makassar.  Methods: The research samples 
are from the results of the antibiotic sensitivity test 
conducted at two different hospitals, Hasanuddin 
University Hospital and Dr. Wahidin Sudirohusodo 
Hospital, from January 1 to September 30, 2019. A total of 
84 samples were cultured and tested for antibiotic 
sensitivity of Pseudomonas aeruginosa. Results: 
Antibiotic sensitivity of P. aeruginosa was best with 
gentamicin (100%) at Hasanuddin University Hospital and 
amikacin (95.8%) at Dr. Wahidin Sudirohusodo Hospital. 
Hasanuddin University Hospital, followed by antibiotics 
amikacin (92.3%) and meropenem (84.6%). At Dr. 
Wahidin Sudirohusodo Hospital, P. aeruginosa showed 
good gentamicin sensitivity (91.5%) and meropenem 









1. INTRODUCTION  
Pseudomonas aeruginosa is an obligate aerobic bacterium and can survive well 
in the environment, such as soil, water, plants, animals, moist surfaces, including in 
hospitals and medical equipment because of its ability to survive with minimal nutritional 
requirements and can tolerate a variety of physical conditions.i P. aeruginosa is also 
known as an opportunistic pathogen in animals and humans. Several reports indicate 
that these bacteria also cause infection in healthy hosts.ii P. aeruginosa is a bacterium 
that can inhabit patients with various diagnoses, especially in immunocompromised 
patients. It causes infections such as pneumonia, gastrointestinal diseases, urinary tract 
infections, sepsis, peritonitis, skin infections, and burns.iii 
Antibiotic resistance is the ability of microorganisms to withstand the effects of 
antibiotics. Pathogenic infections that are resistant to antibiotics require a longer, more 
complex, and expensive treatment. Currently, antibiotic resistance is a global health 
problem, both in developed and developing countries.iv 
Due to high antibiotic resistance and the ability to develop new resistance during 
antibiotic treatment, P. aeruginosa infections are challenging to eradicate. They can 
become persistent or even chronic, as physical therapy becomes difficult and 
ineffective.v Several mechanisms that affect resistance that influence β-lactam 
resistance in P. aeruginosa is the destruction of the β-lactamase enzyme in antibiotics, 
changes in the target of antibiotics, decreased intracellular uptake of antibiotics.vi 
Assessment of the antibiotic susceptibility of nosocomial infectious agents, 
especially P. Aeruginosa, can lead to selecting appropriate treatment and prevention and 
control of the emergence of antibiotic resistance in the hospital environment. This study 
aims to describe the antibiotic sensitivity pattern in clinical isolates of Pseudomonas 
aeruginosa.  
 
2.  METHODS  
The research data were from the antibiotic sensitivity tests conducted at two 
hospitals, the Microbiology Laboratory of Hasanuddin University Hospital and the Clinical 
Pathology Laboratory of Dr. Wahidin Sudirohusodo Hospital. The samples were all 
culture data and antibiotic sensitivity tests from various clinical specimens of patients 
identified as P. aeruginosa at Hasanuddin University Hospital and Dr. Wahidin 
Sudirohusodo Hospital, from 1 to September 30, 2019. The inclusion criteria are the 
sample with the results of the identification test using VITEK 2-Compact was 
Pseudomonas aeruginosa and the exclusion criteria for the study were incomplete data 
from both the antibiotic sensitivity test and the patient's diagnosis. There are 13 clinical 
isolates from the Hasanuddin University Hospital 71 clinical isolates of P. aeruginosa 
from Dr. Wahidin Sudirohusodo Hospital. 
Samples of clinical isolates of P. aeruginosa bacteria are from several 
specimens, such as sputum, urine, pus, blood, body fluid, ear secretions, and tissues 
piperacillin/tazobactam. Conclusions:  This study shows 
that the effectiveness of meropenem, amikacin, and 
gentamicin are great. It can use as a treatment option in 
P. aeruginosa infection. 
 Copyright © 2021 NMSJ. All rights reserved. 






which were detected using the VITEK 2-Compact. Antibiotic sensitivity tests were also 
carried out with the VITEK 2-Compact. The antibiotics used were ceftazidime (CAZ), 
meropenem (MEM), amikacin (AK), gentamicin (GN), and piperacillin/tazobactam (TZP). 
Data on culture examination and antibiotic sensitivity tests were obtained from 
patient medical records at Hasanuddin University Hospital and Dr. Wahidin 
Sudirohusodo Hospital. The data recorded included name, date of birth, medical record 
number, gender, antibiotic therapy for patient diagnosis, the antibiotic sensitivity pattern, 
and type of specimen. Then re-examination of the completeness of the data in the 
laboratory of each hospital. 
 
3.  RESULTS  
In this study, there were 13 clinical isolates of P. aeruginosa from Hasanuddin 
University Hospital, which were isolated from pus (23.1%), sputum (53.8%), ear 
secretions (15.4%), and tissue (7.7%). In Dr. Wahidin Sudirohusodo Hospital, there were 
71 clinical isolates isolated from several specimens, including pus (40.8%), sputum 
(33.8%), tissue (7.1%), blood (7.1%), ear secretions (4.2 %), urine (2.8%), and body 
fluids (4.2%). From a total sample of two hospitals, each 7 (53.8%) isolates and 45 
(63.4%) isolates were taken from male patients, 6 isolates (46.2%) and 26 (36.6%) 
isolates were taken from female patients. The most age group was between 46-65 years 
as many as 6 (46.2%) isolates from Hasanuddin University Hospital and 26 (36.6%) 
isolates from Dr. Wahidin Sudirohusodo Hospital. The distribution of P. aeruginosa 
samples based on the type of specimen, sex, and age group shows in table 1. 
 
Table 1. Distribution of Pseudomonas aeruginosa
 
*Age group based on Depkes, 2009 
Source: Primary Data, 2019 
The distribution of P.aeruginosa samples was also grouped based on the 
category of patient diagnosis. For Hasanuddin University Hospital, the diagnosis of most 
patients was respiratory disease as many as 6 (46.2%) isolates followed by ear nose 
and throat disease is 2 (15.4%) isolates. Most diagnoses from Dr. Wahidin Sudirohusodo 
Hospital, with 13 (18.3%) isolates of nervous disease followed by 12 (17%) isolates of 
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respiratory illness. The distribution of P. aeruginosa samples based on the type of 
patient’s diagnosis shows in table 2. 
Table 2. Distribution of Pseudomonas aeruginosa based on patient’s diagnosis 
 
*Etc: Sepsis, Hematological Disease, Abscess 
Source: Primary Data 2019 
 
The antibiotic sensitivity pattern of P. aeruginosa shows in Figure 1. Of the five 
types of antibiotics, the sensitivity of P. aeruginosa is best with the aminoglycoside 
antibiotics, including gentamicin (100%) at Hasanuddin University Hospital and amikacin 
(95.8%) at Dr. Wahidin Sudirohusodo Hospital. At Hasanuddin University Hospital 
followed by antibiotics amikacin (92.3%) and meropenem (84.6%). The sensitivity of P. 
aeruginosa was lowest to piperacillin/tazobactam antibiotics, but the figure was 69.2%. 
At Dr. Wahidin Sudirohusodo Hospital, P. aeruginosa also showed good sensitivity to 
gentamicin (91.5%) and meropenem (77.5%), while the lowest sensitivity shows in 
piperacillin/tazobactam (60.5%). 
Pseudomonas aeruginosa which was resistant to several antibiotics also linked 
based on the type of specimen. Dr. Wahidin Sudirohusodo Hospital obtained samples 
with the most resistance from pus specimens that were resistant to ceftazidime (34.5%), 
meropenem (27.6%), and tazobactam/piperacillin (24.1%), followed by samples from 
sputum specimens which resistant to ceftazidime (20.8%). At Hasanuddin University 
Hospital, the sample with the most resistance was sputum specimens with the highest 
resistance to tazobactam/piperacillin (14,3%). The distribution of resistance samples of 
Pseudomonas aeruginosa based on the type of specimen is shown in table 3. 







Figure 1. Antibiotic sensitivity pattern in clinical isolates of Pseudomonas aeruginosa 
 
Table 3. Distribution of resistance samples of Pseudomonas aeruginosa based on the type of 
specimen 
 
*CAZ=ceftazidime, MEM=meropenem, AK=amikacin, GN=gentamicin, TZP=tazobactam-piperacillin 
Source: Secondary Data 2019 
 
4. DISCUSSIONS 
Pseudomonas aeruginosa is a nosocomial and opportunistic pathogen that is 
often isolated because it causes several infections, including respiratory tract infections, 
burns, otitis media, and other diseases with high mortality prevalence, especially in 
immunocompromised patients who are hospitalized.vii P. aeruginosa has intrinsic 
resistance to various antibiotics and can acquire resistance to other antibiotics during 
therapy.viii The ability of P. aeruginosa resistance is known to increase and become a 
global public health problem worldwide.ix 
This study showed that P. aeruginosa was more isolated from male patients 
where from a total sample of two hospitals, 7 (53.8%) isolates and 45 (63.4%) isolates 
were taken from male patients, respectively. The highest age group was between 46-65 
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years in both hospitals, which is in line with research conducted by Omar B. Ahmed in 
2017 in Saudi Arabia, which showed that out of 28 isolates, there were 18 (64.3%) 
isolates from male patients. However, it is contrary to the age group wherein the 
dominant age group is above 60 years.5 For the origin of the specimens in this study, 
most samples came from pus and sputum at both hospitals. National Antimicrobial 
Resistance Surveillance, Thailand (NARST) also reported that P. aeruginosa was most 
commonly found in pus, urine, and sputum specimens.x 
In this study, the isolated P. aeruginosa isolates had different levels of sensitivity 
to several antibiotics. The highest level of sensitivity was to the antibiotic gentamicin 
(100%) for the Hasanuddin University Hospital and amikacin (95.8%) at Dr. Wahidin 
Sudirohusodo Hospital. These results are in line with the research conducted by Dewi et 
al in Pekanbaru, which showed the level of sensitivity to amikacin (76.9%) from a total 
of 121 isolates of Pseudomonas aeruginosa; 93 isolates were sensitive to amikacin.xi 
Nahid Bavasheh et al. in Iran also showed a good level of sensitivity to amikacin (19.4%) 
that from 72 isolates, 58 isolates were sensitive to amikacin.4 
The resistance of several antibiotics in this study is most likely due to the 
prolonged hospitalization time in infectious patients, the use of broad-spectrum drugs at 
the start of hospitalization, the lack of routine screening for ESBL-producing P. 
aeruginosa strains, and colonization of multidrug-drug strains resistant. Possible 
mechanisms of resistance to antibiotics in this study including overproduction of AmpC, 
a cephalosporinase expressed by the P. aeruginosa chromosomal gene, which causes 
the most common resistance mechanisms to b-lactams including ESBLs (eg, 
ceftazidime) and penicillins. Several studies have reported the increasig resistance of P. 
aeruginosa isolates to cephalosporins.xii,xiii,xiv 
Carbapenem antibiotics are currently considered the drug of choice to treat the 
infections caused by ESBL-producing organisms, including Pseudomonas aeruginosa. 
In this study, 11 (84.6%) isolates at Hasanuddin University Hospital and 55 (77.5%) 
isolates at Dr. Wahidin Sudirohusodo Hospital are sensitive to meropenem. The result is 
in line with research conducted by Martina C. Agbo et al. in May until August 2018 at a 
Hospital in Nigeria, which stated that of 34 clinical isolates of P. aeruginosa there were 
29 isolates (85.3%) sensitive to the antibiotic meropenem.xv Another study that is in line 
with the results of this study is the study of Mohammad Yousef Alikhani in Iran where 
from 106 isolates, sensitivity to the antibiotic meropenem was shown by 87 isolates 
(82.1%).xvi This proves that the introduction of carbapenems as a therapy for infection is 
a significant advance. Carbapenems have become the drug of choice in infections 




This study shows that the level of effectiveness of meropenem, amikacin, and 
gentamicin are great. It can use as a treatment option in P. aeruginosa infection. This 
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